Quarterly report pursuant to Section 13 or 15(d)

Segment Reporting - Segment Reporting Financial Information (Details)

v3.20.2
Segment Reporting - Segment Reporting Financial Information (Details) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Revenues $ 15,410,553 $ 12,726,377 $ 41,644,832 $ 34,575,732
Depreciation and amortization 714,288 538,372 2,061,937 1,308,515
Operating income (loss) 1,705,356 640,379 2,717,290 2,071,655
Bargain purchase gain 0 0 0 19,298
Other expense, net (25,667) (16,697) (55,248) (43,469)
Income before income tax expense 1,679,689 623,682 2,662,042 2,047,484
Operating segments        
Operating income (loss) 4,718,440 3,695,837 11,441,180 10,120,186
Unallocated corporate        
Operating income (loss) (3,013,084) (3,055,458) (8,723,890) (8,048,531)
Corporate clinics        
Revenues 8,403,844 6,829,576 22,554,946 18,245,940
Depreciation and amortization 636,734 489,623 1,828,643 1,155,779
Operating income (loss) 1,313,717 821,228 2,662,643 2,225,252
Franchise operations        
Revenues 7,006,709 5,896,801 19,089,886 16,329,792
Depreciation and amortization 342 342 1,027 799
Operating income (loss) 3,404,723 2,874,609 8,778,537 7,894,934
Corporate administration        
Depreciation and amortization $ 77,212 $ 48,407 $ 232,267 $ 151,937